Mesothelin as a diagnostic biomarker in endometriosis: A cross-sectional study
Advances in Medical Sciences · 2026-03 · 71 (1) · 1-8
DOI: 10.1016/j.advms.2025.11.002 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Advances in Medical Sciences, 2026-03. Verfasst von Kamil Kiecka und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland; Angelius Provita Hospital, Katowice, Poland. Hauptthemen laut MEDLINE: Endometriosis, GPI-Linked Proteins, Biomarkers. Die Arbeit nennt 75 Literaturangaben. Gefördert von: Ministerstwo Edukacji i Nauki, Ministerstwo Zdrowia.
Abstract (Originalsprache)
PURPOSE: Endometriosis is a prevalent gynecological condition often requiring invasive procedures for diagnosis. This study aimed to assess mesothelin (MSLN) as a potential non-invasive biomarker by analyzing its levels in peritoneal fluid (PF) and plasma. MATERIALS/METHODS: In a multicenter cross-sectional study, MSLN concentrations were measured using Surface Plasmon Resonance imaging (SPRi) biosensors in samples from women undergoing laparoscopy for pelvic pain or infertility. RESULTS: Significantly higher MSLN levels were observed in the PF of patients with endometriosis compared to controls (mean concentrations: 10.24 vs. 9.39 ng/mL, p = 0.038). The elevation was particularly notable in patients with stage I and II endometriosis compared to the control group (mean concentrations: 10.83 vs. 9.39 ng/mL, p = 0.049). No significant differences were observed in plasma. CONCLUSIONS: Mesothelin in PF may be considered as a potential biomarker for endometriosis, especially in its early stages. Further studies are needed to confirm its diagnostic value.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland; Angelius Provita Hospital, Katowice, Poland.
- OVIklinika Infertility Center, Warsaw, Poland.
- Bioanalysis Laboratory, Faculty of Chemistry, University of Bialystok, Bialystok, Poland.
- Department of Gynecology and Gynecological Oncology, Medical University of Bialystok, Bialystok, Poland.
- Department of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, Bialystok, Poland.
- Second Department of Obstetrics and Gynecology, Center of Postgraduate Medical Education, Warsaw, Poland; Department of Gynecology, Warsaw Institute of Women's Health, Warsaw, Poland; Development and Research Center of…
Förderung
- Ministerstwo Edukacji i Nauki
- Ministerstwo Zdrowia
Zitieren
APA
Kiecka, K., Zygula, A., Sankiewicz, A., Kuzmicki, M., Lawicki, S., Ciebiera, M., Issat, T., Blaszczyk, J., Cendrowski, K., Gorodkiewicz, E., & Laudanski, P. (2026). Mesothelin as a diagnostic biomarker in endometriosis: A cross-sectional study. Advances in Medical Sciences, 71(1), 1-8. https://doi.org/10.1016/j.advms.2025.11.002
Vancouver
Kiecka K, Zygula A, Sankiewicz A, Kuzmicki M, Lawicki S, Ciebiera M, et al. Mesothelin as a diagnostic biomarker in endometriosis: A cross-sectional study. Advances in Medical Sciences. 2026;71(1):1-8. doi:10.1016/j.advms.2025.11.002
BibTeX
@article{Kiecka2026,
author = {Kiecka, Kamil and Zygula, Aleksandra and Sankiewicz, Anna and Kuzmicki, Mariusz and Lawicki, Slawomir and Ciebiera, Michal and Issat, Tadeusz and Blaszczyk, Jan and Cendrowski, Krzysztof and Gorodkiewicz, Ewa and Laudanski, Piotr},
title = {Mesothelin as a diagnostic biomarker in endometriosis: A cross-sectional study},
journal = {Advances in Medical Sciences},
year = {2026},
volume = {71},
number = {1},
pages = {1--8},
doi = {10.1016/j.advms.2025.11.002}
}
EUVIMED